Magnesium level and impulsivity during ketamine administration for treatment-resistant mood disorders.
Magnesium Research Jakub Słupski, Adam Włodarczyk, Natalia Górska et al.
Impulsive behaviours affect patients with major depressive disorder (MDD) and bipolar disorder (BP), increasing suicide risk and mood instability. Ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, has been reported to promote fast-acting antidepressive and antisuicidal effects. Magnesium administered contemporarily with low-dose NMDA antagonists has been shown to cause a reduction...
DOI: 10.1684/mrh.2024.0534 (opens in new tab)
Full text (opens in new tab)
Impulsivity
Mood disorders
Ketamine therapy
Treatment-resistant depression trd
+2